Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
5-chloro-6-methyl-N-(2-phenylethyl)-2-pyridin-2-ylpyrimidin-4-amine
- Development stage
- Unknown
- Modality
- Small Molecules
01
Overview
A synthetic small molecule featuring a pyridine and pyrimidine core structure, substituted with chloro, methyl, and phenylethyl groups. It is classified as a pyrimidylpyridine derivative. The compound has been referenced in chemical databases but does not have an established pharmaceutical use or approved indication. It is known to interact with methionine aminopeptidase enzymes (MAP1 and MAP2), suggesting potential activity as an inhibitor of these targets[1][2]. Methionine aminopeptidases are involved in the removal of N-terminal methionine residues from nascent proteins—a process relevant to cell growth and proliferation.
- Other names
- 5-chloro-6-methyl-N-(2-phenylethyl)-2-pyridin-2-ylpyrimidin-4-amine5-chloro-6-methyl-N-(2-phenyethyl)-2-pyridinylpyrimidinamin5-chloro-6-methyl-N-(2-phenyethyl)-2-(pyridinyl)pyrimidinamin4-pyrimidinamine, 5-chloro–6-methyl–N–(2–phenylethyl)–2–(pyridin–2–yl)–
02
Targets
METAP2 (Methionine aminopeptidase 2)METAP1 (Methionine aminopeptidase 1)
Beyond the preview
Go deeper on 5-chloro-6-methyl-N-(2-phenylethyl)-2-pyridin-2-ylpyrimidin-4-amine.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on 5-chloro-6-methyl-N-(2-phenylethyl)-2-pyridin-2-ylpyrimidin-4-amine.